Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer. [electronic resource]
Producer: 20120730Description: 631-4 p. digitalISSN:- 1095-6859
- Antineoplastic Agents, Phytogenic -- economics
- Antineoplastic Combined Chemotherapy Protocols -- economics
- Carboplatin -- administration & dosage
- Docetaxel
- Drug Costs -- statistics & numerical data
- Female
- Humans
- Markov Chains
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Quality of Life
- Taxoids -- administration & dosage
- United States
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.